LT4 monotherapy remains the standard treatment for hypothyroidism, although a subset of patients continues to have ...

A new combination therapy is showing promise in reducing facial redness caused by rosacea, a common skin condition.

[5] This was the rationale for the Medical Therapy of Prostatic Symptoms (MTOPS) study. Rather than concentrate on the effect of combination therapy on longitudinal changes, the aim of this trial ...

The observed changes were favorable, but results may have been affected by better-than-normal care in the control arm.

Penpulimab in combination therapy for the first-line treatment of metastatic NPC, has had its marketing application accepted by the NMPA and the FDA. Additionally, the marketing application for its ...

The differentiated clinical value of the penpulimab combination therapy is expected to offer a more effective solution for patients with liver cancer. The sNDA for this new indication is supported ...

The Wistar Institute's Nan Zhang, Ph.D., assistant professor in the Ellen and Ronald Caplan Cancer Center's Molecular and Cellular Oncogenesis Program, and colleagues have discovered a new approach to ...

CURE® spoke with a lung cancer treatment expert about study findings showing survival benefits with the addition of ...

Ever since former cricketer Navjot Singh Sidhu said how natural methods — fasting, not eating sugar or dairy, having bitter ...

Wistar Institute scientists have discovered a new approach to treating ovarian cancer that, in preclinical laboratory testing, shrinks tumors and improves survival rates while simultaneously making ...